Analyst Price Targets — ASTH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 14, 2026 11:04 am | David Larsen | BTIG | $65.00 | $47.64 | TheFly | Astrana Health price target raised to $65 from $50 at BTIG |
| May 26, 2026 12:54 pm | — | Barclays | $50.00 | $39.00 | TheFly | Astrana Health upgraded to Overweight from Equal Weight at Barclays |
| May 14, 2026 1:25 pm | — | Truist Financial | $47.00 | $39.39 | TheFly | Astrana Health price target raised to $47 from $38 at Truist |
| May 11, 2026 9:21 am | — | Barclays | $37.00 | $39.30 | TheFly | Astrana Health price target raised to $37 from $26 at Barclays |
| May 8, 2026 1:53 pm | Matthew Shea | Needham | $41.00 | $37.90 | TheFly | Astrana Health price target raised to $41 from $30 at Needham |
| May 8, 2026 12:43 pm | — | Robert W. Baird | $45.00 | $36.03 | TheFly | Astrana Health price target raised to $45 from $40 at Baird |
| April 15, 2026 10:18 am | — | Robert W. Baird | $40.00 | $29.07 | TheFly | Astrana Health price target raised to $40 from $37 at Baird |
| February 2, 2026 12:14 pm | — | BTIG | $40.00 | $22.74 | TheFly | Astrana Health price target lowered to $40 from $45 at BTIG |
| December 12, 2025 11:23 am | Matthew Shea | Needham | $28.00 | $22.46 | TheFly | Astrana Health initiated with a Buy at Needham |
| November 25, 2025 4:33 pm | — | Jefferies | $37.00 | $22.91 | TheFly | Astrana Health price target lowered to $37 from $44 at Jefferies |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for ASTH

ALHAMBRA, Calif., July 14, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the second quarter ended June 30, 2026,…

Names Daniel Rothman President of Physician Enterprise and Vishal Gupta Senior Vice President of Enterprise Transformation ALHAMBRA, Calif., July 13, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and…

All Eight ACOs Achieve Net Shared Savings ALHAMBRA, Calif., July 13, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that its Accountable Care Organizations…

Astrana Health, Inc. (ASTH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

ALHAMBRA, Calif., June 4, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced it has been named to the Fortune 1000® for 2026, marking its debut on the annual…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ASTH.
U.S. House Trading
No House trades found for ASTH.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
